Does Methotrexate Increase Blood Pressure

Low-dose methotrexate is not effective at lowering blood pressure in patients without rheumatic disease. A major effect on blood pressure in patients treated with MTX for autoimmune diseases is unlikely. Methotrexate (MTX) use can be associated with a variety of adverse effects over a wide range of severity (table 1); the risk of most adverse effects is influenced by the MTX dose and treatment regimen.

Methotrexate can cause many side effects, ranging from nausea to nerve cell damage. Talk to your healthcare provider about any side effects you might be experiencing. This can help you manage them early and make sure your treatment is safe.

There are ways to prevent methotrexate side effects. RA patients on MTX treatment had significantly lower clinic and 24-hour peripheral and central BP compared to those who did not take MTX. The lower BP with MTX may be related to differences in PWV, but not in AIx or ADMA concentrations.

Methotrexate is a medication that treats arthritis, psoriasis and other inflammatory conditions. It decreases inflammation in your body. Low dose methotrexate (LD-MTX) reduces cardiovascular disease (CVD) risk in patients with systemic rheumatic diseases, but its effects on the general population remain unclear.

Researchers conducted a retrospective study to examine the effect of LD-MTX on blood pressure (BP). Methotrexate significantly lowered blood pressure compared to another arthritis drug called sulfasalazine, researchers reported recently in the Annals of Medicine. Treatment with low-dose methotrexate had minimal impact on blood pressure compared with placebo and did not impact the risk for cardiovascular disease events.

A phase IV clinical study of FDA data: High blood pressure is found as a side effect among people who take Methotrexate (methotrexate sodium) A new study led by Flinders University and Southern Adelaide Local Health Network (SALHN) researchers, has shown that methotrexate significantly lowers blood pressure when compared to another arthritis drug, sulfasalazine, marking the first clear evidence of this effect in newly diagnosed patients.